Compile Data Set for Download or QSAR
Found 4402 with Last Name = 'wright' and Initial = 'sw'
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360584(CHEMBL1933350)
Show SMILES CCC[C@@H]([C@@H](c1c[nH]c2c(F)cc(C)cc12)c1ccc(Cl)cc1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C30H30ClFN2O3/c1-3-4-23(19-5-7-21(8-6-19)30(37)33-14-13-27(35)36)28(20-9-11-22(31)12-10-20)25-17-34-29-24(25)15-18(2)16-26(29)32/h5-12,15-17,23,28,34H,3-4,13-14H2,1-2H3,(H,33,37)(H,35,36)/t23-,28+/m1/s1
Affinity DataKi:  4nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetMineralocorticoid receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50398061(CHEMBL2181928)
Show SMILES C[C@@H]1CN([C@@H](CO1)c1ccccc1)c1ccc2OCC(=O)Nc2n1
Show InChI InChI=1S/C18H19N3O3/c1-12-9-21(14(10-23-12)13-5-3-2-4-6-13)16-8-7-15-18(19-16)20-17(22)11-24-15/h2-8,12,14H,9-11H2,1H3,(H,19,20,22)/t12-,14+/m1/s1
Affinity DataKi:  6.30nMAssay Description:Displacement of [3H]-aldosterone from human GST-tagged MR ligand binding domain after 4 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  17nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  17nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  48nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  48nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360597(CHEMBL1933363)
Show SMILES CCCC(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H25F3N4O3/c1-2-3-21(16-4-6-17(7-5-16)23(34)28-13-12-22(32)33)30-19-14-29-31(15-19)20-10-8-18(9-11-20)24(25,26)27/h4-11,14-15,21,30H,2-3,12-13H2,1H3,(H,28,34)(H,32,33)
Affinity DataKi:  67nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360597(CHEMBL1933363)
Show SMILES CCCC(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H25F3N4O3/c1-2-3-21(16-4-6-17(7-5-16)23(34)28-13-12-22(32)33)30-19-14-29-31(15-19)20-10-8-18(9-11-20)24(25,26)27/h4-11,14-15,21,30H,2-3,12-13H2,1H3,(H,28,34)(H,32,33)
Affinity DataKi:  67nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360601(CHEMBL1933349 | MK-0893)
Show SMILES COc1ccc2cc(ccc2c1)-c1cc(nn1[C@@H](C)c1ccc(cc1)C(=O)NCCC(O)=O)-c1cc(Cl)cc(Cl)c1
Show InChI InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1
Affinity DataKi:  70nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50244455((R)-3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichl...)
Show SMILES O[C@H](CNC(=O)c1ccc(CN(C(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(cc2)C2=CCCCC2)cc1)C(O)=O
Show InChI InChI=1S/C30H29Cl2N3O5/c31-23-14-24(32)16-25(15-23)34-30(40)35(26-12-10-21(11-13-26)20-4-2-1-3-5-20)18-19-6-8-22(9-7-19)28(37)33-17-27(36)29(38)39/h4,6-16,27,36H,1-3,5,17-18H2,(H,33,37)(H,34,40)(H,38,39)/t27-/m1/s1
Affinity DataKi:  85nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  91nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  91nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360589(CHEMBL1933355)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(CC)cc1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C25H29N3O4/c1-3-5-23(19-8-10-20(11-9-19)25(31)26-15-14-24(29)30)32-22-16-27-28(17-22)21-12-6-18(4-2)7-13-21/h6-13,16-17,23H,3-5,14-15H2,1-2H3,(H,26,31)(H,29,30)
Affinity DataKi:  214nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360600(CHEMBL1933348)
Show SMILES CCCc1c(cc(C(C)C)c(C(C)O)c1-c1ccc(F)cc1)C(C)C
Show InChI InChI=1S/C23H31FO/c1-7-8-19-20(14(2)3)13-21(15(4)5)22(16(6)25)23(19)17-9-11-18(24)12-10-17/h9-16,25H,7-8H2,1-6H3
Affinity DataKi:  356nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360588(CHEMBL1933354)
Show SMILES CCCC(Oc1cnn(c1)-c1cccc(CC)c1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C25H29N3O4/c1-3-6-23(19-9-11-20(12-10-19)25(31)26-14-13-24(29)30)32-22-16-27-28(17-22)21-8-5-7-18(4-2)15-21/h5,7-12,15-17,23H,3-4,6,13-14H2,1-2H3,(H,26,31)(H,29,30)
Affinity DataKi:  556nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360591(CHEMBL1933357)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(Cl)cc1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C23H24ClN3O4/c1-2-3-21(16-4-6-17(7-5-16)23(30)25-13-12-22(28)29)31-20-14-26-27(15-20)19-10-8-18(24)9-11-19/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,25,30)(H,28,29)
Affinity DataKi:  600nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  927nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  927nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360587(CHEMBL1933353)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(C)cc1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H27N3O4/c1-3-4-22(18-7-9-19(10-8-18)24(30)25-14-13-23(28)29)31-21-15-26-27(16-21)20-11-5-17(2)6-12-20/h5-12,15-16,22H,3-4,13-14H2,1-2H3,(H,25,30)(H,28,29)
Affinity DataKi:  968nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360590(CHEMBL1933356)
Show SMILES CCCC(Oc1cnn(c1)-c1cccc(Cl)c1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C23H24ClN3O4/c1-2-4-21(16-7-9-17(10-8-16)23(30)25-12-11-22(28)29)31-20-14-26-27(15-20)19-6-3-5-18(24)13-19/h3,5-10,13-15,21H,2,4,11-12H2,1H3,(H,25,30)(H,28,29)
Affinity DataKi:  1.09E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360586(CHEMBL1933352)
Show SMILES CCCC(Oc1cnn(c1)-c1cccc(C)c1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H27N3O4/c1-3-5-22(18-8-10-19(11-9-18)24(30)25-13-12-23(28)29)31-21-15-26-27(16-21)20-7-4-6-17(2)14-20/h4,6-11,14-16,22H,3,5,12-13H2,1-2H3,(H,25,30)(H,28,29)
Affinity DataKi:  1.11E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360595(CHEMBL1933361)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cn1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C23H23F3N4O4/c1-2-3-19(15-4-6-16(7-5-15)22(33)27-11-10-21(31)32)34-18-13-29-30(14-18)20-9-8-17(12-28-20)23(24,25)26/h4-9,12-14,19H,2-3,10-11H2,1H3,(H,27,33)(H,31,32)
Affinity DataKi:  1.19E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360596(CHEMBL1933362)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(nc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C23H23F3N4O4/c1-2-3-19(15-4-6-16(7-5-15)22(33)27-11-10-21(31)32)34-18-13-29-30(14-18)17-8-9-20(28-12-17)23(24,25)26/h4-9,12-14,19H,2-3,10-11H2,1H3,(H,27,33)(H,31,32)
Affinity DataKi:  1.45E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360597(CHEMBL1933363)
Show SMILES CCCC(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H25F3N4O3/c1-2-3-21(16-4-6-17(7-5-16)23(34)28-13-12-22(32)33)30-19-14-29-31(15-19)20-10-8-18(9-11-20)24(25,26)27/h4-11,14-15,21,30H,2-3,12-13H2,1H3,(H,28,34)(H,32,33)
Affinity DataKi:  1.95E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360593(CHEMBL1933359)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(OC)cc1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H27N3O5/c1-3-4-22(17-5-7-18(8-6-17)24(30)25-14-13-23(28)29)32-21-15-26-27(16-21)19-9-11-20(31-2)12-10-19/h5-12,15-16,22H,3-4,13-14H2,1-2H3,(H,25,30)(H,28,29)
Affinity DataKi:  1.98E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280213((E)-11-(3-Pentyl-thiiranyl)-undec-9-enoic acid | C...)
Show SMILES CCCCCC1SC1C\C=C\CCCCCCCC(O)=O
Show InChI InChI=1S/C18H32O2S/c1-2-3-10-13-16-17(21-16)14-11-8-6-4-5-7-9-12-15-18(19)20/h8,11,16-17H,2-7,9-10,12-15H2,1H3,(H,19,20)/b11-8+
Affinity DataKi:  2.00E+3nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360592(CHEMBL1933358)
Show SMILES CCCC(Oc1cnn(c1)-c1cccc(OC)c1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H27N3O5/c1-3-5-22(17-8-10-18(11-9-17)24(30)25-13-12-23(28)29)32-21-15-26-27(16-21)19-6-4-7-20(14-19)31-2/h4,6-11,14-16,22H,3,5,12-13H2,1-2H3,(H,25,30)(H,28,29)
Affinity DataKi:  2.16E+3nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  3.84E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  3.84E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280211(11-(3-Pentyl-thiiranyl)-undecanoic acid | CHEMBL28...)
Show SMILES CCCCCC1SC1CCCCCCCCCCC(O)=O
Show InChI InChI=1S/C18H34O2S/c1-2-3-10-13-16-17(21-16)14-11-8-6-4-5-7-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)
Affinity DataKi:  4.00E+3nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  4.08E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  4.08E+3nMAssay Description:Displacement of [125I]GIP from human GIPRMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  4.22E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360598(CHEMBL1933364)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(CCC(F)(F)F)Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F
Show InChI InChI=1S/C24H22F6N4O3/c25-23(26,27)11-9-20(15-1-3-16(4-2-15)22(37)31-12-10-21(35)36)33-18-13-32-34(14-18)19-7-5-17(6-8-19)24(28,29)30/h1-8,13-14,20,33H,9-12H2,(H,31,37)(H,35,36)
Affinity DataKi:  4.22E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  6.62E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360599(CHEMBL1933365)
Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)C1CCCC1
Show InChI InChI=1S/C26H27F3N4O3/c27-26(28,29)20-9-11-22(12-10-20)33-16-21(15-31-33)32-24(17-3-1-2-4-17)18-5-7-19(8-6-18)25(36)30-14-13-23(34)35/h5-12,15-17,24,32H,1-4,13-14H2,(H,30,36)(H,34,35)
Affinity DataKi:  6.62E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360597(CHEMBL1933363)
Show SMILES CCCC(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H25F3N4O3/c1-2-3-21(16-4-6-17(7-5-16)23(34)28-13-12-22(32)33)30-19-14-29-31(15-19)20-10-8-18(9-11-20)24(25,26)27/h4-11,14-15,21,30H,2-3,12-13H2,1H3,(H,28,34)(H,32,33)
Affinity DataKi:  9.08E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360597(CHEMBL1933363)
Show SMILES CCCC(Nc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H25F3N4O3/c1-2-3-21(16-4-6-17(7-5-16)23(34)28-13-12-22(32)33)30-19-14-29-31(15-19)20-10-8-18(9-11-20)24(25,26)27/h4-11,14-15,21,30H,2-3,12-13H2,1H3,(H,28,34)(H,32,33)
Affinity DataKi:  9.08E+3nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360585(CHEMBL1933351)
Show SMILES CCCC(Oc1cnn(c1)-c1ccccc1C)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H27N3O4/c1-3-6-22(18-9-11-19(12-10-18)24(30)25-14-13-23(28)29)31-20-15-26-27(16-20)21-8-5-4-7-17(21)2/h4-5,7-12,15-16,22H,3,6,13-14H2,1-2H3,(H,25,30)(H,28,29)
Affinity DataKi:  1.47E+4nMAssay Description:Displacement of [125I]Glucagon-Cex from human GCGRMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  1.65E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetGlucagon-like peptide 1 receptor(Homo sapiens (Human))
Pfizer Inc

Curated by ChEMBL
LigandPNGBDBM50360594(CHEMBL1933360)
Show SMILES CCCC(Oc1cnn(c1)-c1ccc(cc1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C24H24F3N3O4/c1-2-3-21(16-4-6-17(7-5-16)23(33)28-13-12-22(31)32)34-20-14-29-30(15-20)19-10-8-18(9-11-19)24(25,26)27/h4-11,14-15,21H,2-3,12-13H2,1H3,(H,28,33)(H,31,32)
Affinity DataKi:  1.65E+4nMAssay Description:Displacement of [125I]GLP-1 from human GLP1RMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280208((E)-11-(3-Pentyl-oxiranyl)-undec-9-enoic acid | CH...)
Show SMILES CCCCCC1OC1C\C=C\CCCCCCCC(O)=O
Show InChI InChI=1S/C18H32O3/c1-2-3-10-13-16-17(21-16)14-11-8-6-4-5-7-9-12-15-18(19)20/h8,11,16-17H,2-7,9-10,12-15H2,1H3,(H,19,20)/b11-8+
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280212(8-[((E)-3-Oct-2-enyl)-thiiranyl]-octanoic acid | C...)
Show SMILES CCCCC\C=C\CC1SC1CCCCCCCC(O)=O
Show InChI InChI=1S/C18H32O2S/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h7,10,16-17H,2-6,8-9,11-15H2,1H3,(H,19,20)/b10-7+
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280210(8-[((E)-3-Oct-2-enyl)-oxiranyl]-octanoic acid | CH...)
Show SMILES CCCCC\C=C\CC1OC1CCCCCCCC(O)=O
Show InChI InChI=1S/C18H32O3/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h7,10,16-17H,2-6,8-9,11-15H2,1H3,(H,19,20)/b10-7+
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280214(8-(3-Octyl-oxiranyl)-octanoic acid | CHEMBL27918)
Show SMILES CCCCCCCCC1OC1CCCCCCCC(O)=O
Show InChI InChI=1S/C18H34O3/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280207(11-(3-Pentyl-oxiranyl)-undecanoic acid | CHEMBL281...)
Show SMILES CCCCCC1OC1CCCCCCCCCCC(O)=O
Show InChI InChI=1S/C18H34O3/c1-2-3-10-13-16-17(21-16)14-11-8-6-4-5-7-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetSeed linoleate 13S-lipoxygenase-1(Glycine max (soybean))
TBA

Curated by ChEMBL
LigandPNGBDBM50280209(8-(3-Octyl-thiiranyl)-octanoic acid | CHEMBL28539)
Show SMILES CCCCCCCCC1SC1CCCCCCCC(O)=O
Show InChI InChI=1S/C18H34O2S/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)
Affinity DataKi: >1.00E+5nMAssay Description:Inhibitory activity of the compound against Soyabean type 1 Lipoxygenase (SBLO) was determinedMore data for this Ligand-Target Pair
TargetPantetheinase(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM50585537(CHEMBL5084938)
Show SMILES O=C(N1CCC2(C1)CCOCC2)c1cnc(NC2(CCC2)c2cnccn2)nc1
Show InChI InChI=1S/C21H26N6O2/c28-18(27-9-4-20(15-27)5-10-29-11-6-20)16-12-24-19(25-13-16)26-21(2-1-3-21)17-14-22-7-8-23-17/h7-8,12-14H,1-6,9-11,15H2,(H,24,25,26)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetPantetheinase(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM480924(US10906888, Example 138)
Show SMILES O=C(N1CC2(C1)CCOCC2)c1cnc(NC2(CCC2)c2cnccn2)nc1
Show InChI InChI=1S/C20H24N6O2/c27-17(26-13-19(14-26)4-8-28-9-5-19)15-10-23-18(24-11-15)25-20(2-1-3-20)16-12-21-6-7-22-16/h6-7,10-12H,1-5,8-9,13-14H2,(H,23,24,25)
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of recombinant N-terminal FLAG/His6-tagged human vanin-1 expressed in CHO cells using Pantetheine-7-amino-4-trifluoromethykournarin as sub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetPantetheinase(Homo sapiens (Human))
Pfizer Inc.

Curated by ChEMBL
LigandPNGBDBM480916(8-oxa-2-azaspiro[4.5]dec-2-yl(2-{[1-(pyrazin-2-yl)...)
Show SMILES O=C(N1CCC2(C1)CCOCC2)c1cnc(NC2(CC2)c2cnccn2)nc1
Show InChI InChI=1S/C20H24N6O2/c27-17(26-8-3-19(14-26)4-9-28-10-5-19)15-11-23-18(24-12-15)25-20(1-2-20)16-13-21-6-7-22-16/h6-7,11-13H,1-5,8-10,14H2,(H,23,24,25)
Affinity DataIC50: 0.0410nMAssay Description:The test inhibitors were solubilized in DMSO to a stock concentration of 30 mM. On the day of the assay, dose response plates were prepared by diluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
Displayed 1 to 50 (of 4402 total ) | Next | Last >>
Jump to: